BIOGEN INC revenue for the last year amounted to 9.66 T CLP, the most of which — 9.60 T CLP — came from its highest performing source at the moment, Innovative Therapies, the year earlier bringing 8.67 T CLP. The greatest contribution to the revenue figure was made by United States — last year it brought BIOGEN INC 5.30 T CLP, and the year before that — 4.79 T CLP.